Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
352 studies found for:    leukemia [CONDITION] AND child [AGE-GROUP] | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)
Condition: Leukemia
Intervention: Drug: Ara-c
2 Recruiting Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALL
Condition: Leukemia
Interventions: Drug: Amsacrine;   Drug: Clofarabine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin hydrochloride;   Drug: Dexamethasone;   Drug: Doxorubicin hydrochloride;   Drug: Etoposide phosphate;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Pegaspargase;   Drug: Thioguanine;   Drug: Vincristine sulfate;   Radiation: Whole-brain radiation therapy
3 Recruiting International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010
Condition: Acute Lymphoblastic Leukemia (ALL)
Interventions: Drug: SR-A + Epratuzumab;   Drug: SR-B + Epratuzumab
4 Recruiting Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HR First Relapse B-precursor ALL
Condition: Leukemia, Acute Lymphoblastic
Interventions: Drug: Blinatumomab;   Drug: Conventional Consolidation Chemotherapy
5 Not yet recruiting International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
Condition: Acute Myeloid Leukaemia
Interventions: Drug: Gemtuzumab ozogamicin;   Drug: Liposomal daunorubicin;   Drug: Mitoxantrone;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Busulfan;   Drug: Cyclophosphamide
6 Recruiting Prevalence of Psychocognitive Impairments in Adolescents Surviving Childhood Leukemia : LEA-PsyCog
Condition: Adolescents Surviving Childhood Leukemia LEA
Intervention: Other: neuropsychological evaluation
7 Recruiting Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML
Condition: Leukemia, Myeloid, Acute
Intervention: Drug: G-CSF
8 Recruiting Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Condition: Leukemia
Interventions: Drug: Bortezomib;   Drug: Pravastatin
9 Recruiting Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children.
Condition: Acute Lymphoblastic Leukemia
Intervention: Other: Blood sample
10 Recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: ITMHA;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: Pegaspargase;   Drug: Asparaginase Erwinia Chrysanthemi;   Drug: Bortezomib;   Drug: Vorinostat;   Drug: Cyclophosphamide;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Leucovorin Calcium;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Vincristine
11 Recruiting The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: 6-mercaptopurine, Methotrexate;   Drug: 6-mercaptopurine, Methotrexate, Vincristine, Dexamethasone
12 Not yet recruiting A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed
Condition: Leukemia, Myeloid, Acute
Intervention: Drug: Volasertib
13 Recruiting Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: ATRA;   Drug: ATRA + IDA
14 Recruiting Epigenetic Reprogramming in Relapse AML
Condition: Leukemia, Acute Myeloid
Interventions: Drug: Decitabine;   Drug: Vorinostat;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim;   Drug: Sorafenib
15 Not yet recruiting Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML
Condition: Acute Myeloid Leukemia
Interventions: Drug: Idarubicin;   Drug: Cytarabine;   Drug: Cyclophosphamide;   Drug: Physician-Directed Regimens without Cyclophosphamide
16 Recruiting Azacytidine Plus FLAG for Relapsed or Refractory AML
Condition: Acute Myeloid Leukemia
Interventions: Drug: Azacytidine;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim
17 Recruiting Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT
Condition: Acute Myeloid Leukemia
Intervention: Drug: Interferon-alpha
18 Recruiting Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine;   Drug: Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
19 Recruiting Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
Condition: Acute Lymphoblastic Leukemia (ALL)
Interventions: Drug: Prednisolone;   Drug: Dexamethasone;   Drug: L-Asparaginase;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Daunorubicin;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: 6-Mercaptopurine;   Drug: Thioguanine;   Drug: Fludarabine;   Drug: Imatinib
20 Recruiting Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation
Condition: Leukemia
Intervention: Other: DLI of the 20 fraction of the UCBT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.